Professional Documents
Culture Documents
CPQBA, University of Campinas, P.O. Box 6171, 13083-970 Campinas, SP, Brazil
Department of Pharmacology, Anesthesiology and Therapeutics, Faculty of Dentistry, University of Campinas, P.O. Box 52, 13414-903 Piracicaba, SP, Brazil
a r t i c l e
i n f o
Article history:
Received 22 April 2010
Received in revised form 2 December 2010
Accepted 14 January 2011
Available online 4 February 2011
Keywords:
Analgesia
Pain mechanism
Natural product
a b s t r a c t
The crude alcoholic extracts obtained from Pterodon pubescens Benth. seeds are widely used in Brazilian folk
medicine as anti-inammatory, analgesic, anti-rheumatic tonics and depurative preparations. We previously
demonstrated the antinociceptive activity on writhing capsaicin, glutamate, and hot-plate tests of two
compounds isolated from P. pubescens: geranylgeraniol (C1) and 6,7-dihydroxyvouacapan-17-oate
methyl ester (C2). This work is a continuation of the previous study investigating the possible mechanisms of
action for compounds C1 and C2, and the differences between them. The present study demonstrated that
when administered intraperitoneally (i.p.): i), compounds C1 and C2 produced signicant anti-allodynic
activity during the acute phase of the Complete Freund's Adjuvant (CFA)-induced persistent pain model;
ii) compound C1 produced signicant anti-hypernociception activity in the carrageenan-induced pain model;
iii) compound C2 presented a signicant loss of activity after p-chlorophenylalanine methyl ester
hydrochloride (PCPA) [5-HT synthesis inhibitor] treatment, suggesting that the mechanisms of action could
be related to either the synthesis or release of serotonin; iv) compound C1 presented a signicant loss of
activity after ondansetron (5-HT3 receptor antagonist) treatment suggesting activity upon 5-HT3 serotonin
receptors; v) compound C1 presented a signicant loss of activity after efaroxan (mixed I1 imidazoline/
2-adrenoceptor antagonist) treatment suggesting the participation of this compound upon imidazoline I1
receptors; and vi) both compounds C1 and C2 did not appear to exert their activity via 5-HT1A, 5-HT2A,
imidazoline I2, 2-adrenoceptor, nitric oxide, GABAA, acetylcholine muscarinic, and nicotinic receptors when
evaluated in acetic acid-induced nociception.
Crown Copyright 2011 Published by Elsevier B.V. All rights reserved.
1. Introduction
Pterodon pubescens Benth. (Leguminosae) seeds are commercially
available at the Brazilian medicinal ora market and the crude alcoholic
extract of this plant is used in folk medicine in anti-inammatory,
analgesic, and anti-rheumatic preparations (Pio Correa, 1975; Lorenzi,
1998). Phytochemical studies of Pterodon genus have revealed the
presence of alkaloids, isoavones, and diterpenes. Furan diterpenes
were identied and isolated from Pterodon species (Mahjan and
Monteiro, 1973; Fascio et al., 1975; Campos et al., 1994; Arriaga et al.,
2000; Spindola et al., 2009). Our previous studies and those by other
research groups have demonstrated that furan diterpenes possessing
vouacapan skeleton are involved with the anti-inammatory, antinociceptive and antiproliferative properties of P. pubescens seed oil
(Nunan et al., 1982; Carvalho et al., 1999; Silva et al., 2004; Spindola
et al., 2009, 2010). Diterpenes 6-hydroxyvouacapan-7-17-lactone
and 6,7-dihydroxyvouacapan-17-oate methyl ester, found in
P. emarginatus and P. polygalaeorus seeds, respectively, were previously
reported to be associated with the anti-inammatory activity of these
species (Nunan et al., 1982). Different authors (Duarte et al., 1996; Silva
et al., 2004; Coelho et al., 2005; Spindola et al., 2010) have suggested a
participation of vouacapan compounds in antinociceptive and antiinammatory activity.
We have previously demonstrated the antinociceptive properties
of compounds geranylgeraniol (C1) and 6,7-dihydroxyvouacapan17-oate methyl ester (C2) isolated from P. pubescens Benth. when
evaluated on writhing, capsaicin, glutamate and hot-plate animal
experimental models (Spindola et al., 2010). In the present study, we
0014-2999/$ see front matter. Crown Copyright 2011 Published by Elsevier B.V. All rights reserved.
doi:10.1016/j.ejphar.2011.01.025
46
Fig. 1. Chemical structures of compounds A) geranylgeraniol (C1), and B) 6,7dihydroxyvouacapan-17-oate methyl ester (C2).
47
48
Fig. 4. Graph demonstrating effect of pre-treatment of animals with PCPA (100 mg/kg, 4
consecutive days, i.p.) on the antinociceptive proles of geranylgeraniol (C1) and
6,7-dihydroxyvouacapan-17-oate methyl ester (C2) (30 mg/kg, i.p.) against the
acetic acid-induced writhing in mice. Each column represents the mean of 6 to
8 animals and the error bar indicates the S.E.M. P 0.05, P 0.01, P 0.001
compared with corresponding control values (injected with vehicle alone); #P 0.05
comparing to the respective agonist group (reversing effect of compounds C1 or C2).
Fig. 5. Graph demonstrating effect of pre-treatment of animals with pindolol (1 mg/kg, i.p.)
on the antinociceptive proles of geranylgeraniol (C1) and 6,7-dihydroxyvouacapan17-oate methyl ester (C2) (30 mg/kg, i.p.) against the acetic acid-induced writhing in
mice. Each column represents the mean of 6 to 8 animals and the error bar indicates the
S.E.M. P 0.001 compared with corresponding control values (injected with vehicle
alone).
4. Discussion
We recently reported a few antinociceptive properties of compounds geranylgeraniol (C1) and 6,7-dihydroxyvouacapan-17oate methyl ester (C2) isolated from P. pubescens Benth. (Fig. 1)
suggesting the exclusion of opioid receptors when evaluated through
the hot-plate test (Spindola et al., 2010). In the present study, we
extend the previous data, investigating the potential anti-allodynic
and anti-hypernociceptive effects, and some antinociceptive mechanisms for C1 and C2 using the writhing test, in order to understand
better their clinical potential use for pain relief. The most relevant
ndings were that given intraperitoneally (i.p.): i) compounds C1 and
C2 produced signicant anti-allodynic effect during the acute phase of
CFA-induced persistent pain model; ii) compound C1 produced
signicant anti-hypernociceptive effect upon the carrageenan-induced pain model; iii) the antinociceptive action of compounds C1
and C2 during the writhing test could be related to serotonergic and
imidazoline systems.
Pain is normally a transitory unpleasant sensation subsequent to a
noxious or potentially injurious stimulus generated in somatic and
visceral tissues. Unlike acute pain, inammatory and neuropathic
pains are often persistent, chronic states. Patients suffering from
chronic pain often experience hypersensitivity to mechanical, thermal
and chemical stimulation in the form of hyperalgesia (aggravated pain
response to normally painful stimuli) and/or allodynia (pain response
to innocuous stimuli) (Levine and Alessandri-Haber, 2007). Our
previous work demonstrated the effectiveness of compounds C1 and
C2 on the writhing, hot plate, capsaicin and glutamate tests,
suggesting their activities related to vanilloid and/or glutamatergic
receptors (Spindola et al., 2010). A growing amount of experimental
data indicates that these receptors are involved in the mechanism of
pain and inammation, and their antagonists might exhibit clinically
potential relevance in the management of pathological pain states,
such as chronic pain (Woolf and Thompson, 1991). Considering the
diverse etiologies and the variety of molecular mechanisms underlying pain hypersensitivity, the approach of targeting ion channels in
primary afferent nociceptive neurons that can contribute to the
detection of physical stimuli, may be an effective approach for
developing more successful therapies for clinical pain syndromes
49
50
51
Voipio, H.M., Baneux, P., Gomez de Segura, I.A., Hau, J., Wolfensohn, S., 2008. Guidelines
for the veterinary care of laboratory animals: report of the FELASA/ECLAM/ESLAV
Joint Working Group on Veterinary Care. Lab. Anim. 42 (1), 111.
Wang, H., Sun, H., Della Penna, K., Benz, R., Xu, J., Gerhold, D., Holder, D., Koblan, K., 2002.
Chronic neuropathic pain is accompanied by global changes in gene expression and
shares pathobiology with neurodegenerative diseases. Neuroscience 114, 529546.
Winter, C.A., Risley, E.A., Nuss, G.W., 1962. Carrageenan-induced edemas in hind paw of the
rat as an assay for anti-inammatory drugs. Proc. Soc. Exp. Biol. Med. 111, 544547.
Woolf, C.J., Thompson, S.W.N., 1991. The induction and maintenance of central
sensitization is dependent on N-methyl-D-aspartic acid receptor activation:
implications for the treatment of post-injury pain hypersensitivity states. Pain
44, 293299.
Yaksh, T.L., Wilson, P.R., 1979. A spinal serotonin terminal system mediates antinociception.
J. Pharmacol. Exp. Ther. 208, 446453.
Yue, C.Q., Ye, J., Li, C.L., Li, R.T., Sun, Q., 2007. Antinociceptive effects of the novel
spirocyclopiperazinium salt compound LXM-10 in mice. Pharmacol. Biochem.
Behav. 86, 643650.